Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 314Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Atripla

02 12Biktarvy

03 1Complera

04 1Complera /Eviplera

05 8Complera/Eviplera

06 14Descovy

07 20Genvoya

08 14Odefsey

09 5Prezista/Prezcobix/Rezolsta/Symtuza

10 7Revenue share - Symtuza

11 15Stribild

12 9Symtuza

13 9Truvada

PharmaCompass

01

Brand Name : Truvada

Emtricitabine

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Truvada

arrow
ChemOutsourcing
Not Confirmed

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,448

2019 Revenue in Millions : 2,813

Growth (%) : -49

blank

02

arrow
ChemOutsourcing
Not Confirmed

03

arrow
ChemOutsourcing
Not Confirmed

04

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Genvoya

arrow
ChemOutsourcing
Not Confirmed

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 3,338

2019 Revenue in Millions : 3,931

Growth (%) : -15

blank

05

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Symtuza

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 488

2019 Revenue in Millions : 379

Growth (%) : 29

blank

06

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Biktarvy

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 7,259

2019 Revenue in Millions : 4,738

Growth (%) : 53

blank

07

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Genvoya

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 3,338

2019 Revenue in Millions : 3,931

Growth (%) : -15

blank

08

Brand Name : Complera/Eviplera

Emtricitabine

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Complera/Eviplera

arrow
ChemOutsourcing
Not Confirmed

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 269

2019 Revenue in Millions : 406

Growth (%) : -34

blank

09

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Descovy

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,861

2019 Revenue in Millions : 1,500

Growth (%) : 24

blank

10

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Odefsey

arrow
ChemOutsourcing
Not Confirmed

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,672

2019 Revenue in Millions : 1,655

Growth (%) : 1

blank